Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-12-18 4:15 pm Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management L.P. | 3,186,077 5.5% | 2,818,071 (+765.77%) | View |
2023-12-11 4:15 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Point72 Asset Management L.P. | 3,470,691 5.1% | 3,470,691 (New Position) | View |
2023-12-01 4:15 pm Purchase | 13G | FARFETCH LTD FTCH | Point72 Asset Management L.P. | 18,765,409 5.3% | 18,765,409 (New Position) | View |
2023-11-20 4:15 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management L.P. | 3,622,136 6.6% | 3,622,136 (New Position) | View |
2023-11-16 5:00 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Point72 Asset Management L.P. | 3,000,000 5.4% | 3,000,000 (New Position) | View |
2023-11-09 4:27 pm Purchase | 13G | KORRO BIO INC KRRO | Point72 Asset Management L.P. | 542,657 6.8% | 542,657 (New Position) | View |
2023-10-31 4:26 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Point72 Asset Management L.P. | 3,520,402 5.1% | 3,520,402 (New Position) | View |
2023-10-20 4:15 pm Purchase | 13G | SEMTECH CORP SMTC | Point72 Asset Management L.P. | 4,660,836 7.3% | 4,660,836 (New Position) | View |
2023-10-18 4:15 pm Purchase | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | Point72 Asset Management L.P. | 4,061,343 5.1% | 4,061,343 (New Position) | View |
2023-10-10 4:59 pm Purchase | 13G | MADISON SQUARE GARDEN ENTMT CO MSGE | Point72 Asset Management L.P. | 2,303,613 5.6% | 2,303,613 (New Position) | View |
2023-10-10 4:05 pm Purchase | 13G | RAPID7 INC RPD | Point72 Asset Management L.P. | 3,092,270 5.1% | 3,092,270 (New Position) | View |
2023-10-05 4:47 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management L.P. | 1,565,829 5.6% | 1,565,829 (New Position) | View |
2023-10-05 4:24 pm Purchase | 13G | TPI COMPOSITES INC TPIC | Point72 Asset Management L.P. | 2,132,171 5% | 2,132,171 (New Position) | View |
2023-10-02 4:45 pm Purchase | 13G | MORPHIC HLDG INC MORF | Point72 Asset Management L.P. | 2,504,383 5.2% | 2,504,383 (New Position) | View |
2023-09-29 4:33 pm Purchase | 13G | BIONOMICS LTD ADS BNOX | Point72 Asset Management L.P. | 119,092,680 8.1% | 119,092,680 (New Position) | View |
2023-09-18 4:24 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Point72 Asset Management L.P. | 3,727,952 5.6% | 3,727,952 (New Position) | View |
2023-09-15 5:11 pm Purchase | 13G | CYBIN INC CYBN | Point72 Asset Management L.P. | 18,950,000 8.1% | 18,950,000 (New Position) | View |
2023-07-27 4:20 pm Purchase | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | Point72 Asset Management L.P. | 1,383,314 6.2% | 1,383,314 (New Position) | View |
2023-07-27 4:15 pm Purchase | 13G | HEALTH CATALYST INC HCAT | Point72 Asset Management L.P. | 2,824,930 5% | 904,677 (+47.11%) | View |
2023-07-20 4:54 pm Purchase | 13G | CHEWY INC CHWY | Point72 Asset Management L.P. | 6,705,883 5.8% | 6,705,883 (New Position) | View |